查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1454232

全球藥物濫用治療市場：按類型、按治療類型、按年齡層、按治療環境、按地區

Global Substance Abuse Treatment Market, By Type, By Treatment Type, By Age Group, By Treatment Setting, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球藥物濫用治療市場價值為118億美元，預計到2031年將達228億美元，2024年至2031年年複合成長率為8.6%。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 118億美元
實際資料 2019-2023 預測期 2024-2031
預測期2023/2024~2030/2031年複合成長率： 8.60% 2030/2031價值預測 228億美元
圖 1. 2023 年全球市場佔有率(%)（按地區）
全球藥物濫用治療市場-IMG1

藥物濫用治療是指旨在控制藥物依賴並支持長期清醒和康復的計劃和活動。藥物濫用障礙，也稱為成癮，涉及強迫性或無法控制地使用有害和成癮物質，儘管它們有負面影響。常見的濫用物質包括酒精、鴉片類藥物、大麻、古柯鹼和興奮劑。藥物濫用障礙的主要症狀包括無法減少攝取量、產生渴望以及在不使用藥物時出現戒斷症狀。患有成癮的人經常會出現自我控制力下降、社交問題、危險使用，有時還會出現身體依賴。藥物濫用治療旨在透過治療性介入、諮詢、藥物治療和社區支持計劃來解決成癮的生物、心理、社會和行為方面的問題。全球藥物濫用率不斷上升，刺激了對有效治療方案的需求。

市場動態：

全球藥物濫用治療市場的推動因素包括藥物濫用疾病盛行率的上升、對治療有效性的認知不斷提高、有利的監管和報銷政策以及新型藥物輔助治療產品的推出。然而，與成癮相關的社會恥辱、低收入地區缺乏治療設施以及違規治療通訊協定等問題可能會抑制市場成長。開拓的數位治療解決方案、綜合護理模式、針對成癮的針對性治療以及向新興市場的擴張為市場參與者提供了關鍵機會。從地區來看，北美因其先進的醫療基礎設施和意識而佔據市場主導地位。然而，亞太地區預計在預測期內將出現良好的成長。

本研究的主要特點

  • 該報告對全球藥物濫用治療市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
  • 它還說明了各個細分市場的潛在收益成長機會，並為該市場提供了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球藥物濫用治療市場的主要企業。
  • 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球藥物濫用治療市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球藥物濫用治療市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素：
  • 藥物和酒精消費量增加
  • 政府和非政府組織的支持擴大
    • 抑制因素
  • 與藥物成癮相關的社會恥辱
  • 缺乏足夠的復健設施
    • 機會
  • 新興國家尚未開發的市場
  • 公司市場佔有率分析
  • 主要亮點
  • 市場趨勢
  • PEST分析
  • 波特的分析
  • 最近的產品核准/發布
  • 合併、收購和合作

第4章全球藥物濫用治療市場－冠狀病毒 (COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章全球藥物濫用治療市場，依類型，2019-2031

  • 酒精
  • 鴉片類藥物（海洛因、處方止痛藥等）
  • 煙草/尼古丁
  • 古柯鹼
  • 大麻
  • 甲基安非他命
  • 其他非法藥物（苯二氮平類藥物等）

第6章全球藥物濫用治療市場，依治療類型，2019-2031

  • 鴉片類藥物
  • 美沙酮
  • Buprenornhine
  • 緩釋性納曲酮
  • 洛非西定
  • 尼古丁
  • 尼古丁替代療法（以貼片、吸入器或口香糖形式提供）
  • 安非他酮
  • Varenicline
  • 酒精
  • 納曲酮
  • Disulfiram
  • Acamprosate
  • 菸草
  • 可樂定
  • 去甲替林
  • 其他（托吡酯、Modafinil等）

第7章 全球藥物濫用治療市場，依年齡層，2019-2031

  • 青年
  • 成人
  • 老年人

第 8 章 全球藥物濫用治療市場（依治療環境），2019-2031 年

  • 門診治療
  • 門診
  • 私人診所
  • 住院治療
  • 復健中心
  • 醫院
  • 住宅治療設施
  • 戒毒中心

第9章全球藥物濫用治療市場，依地區分類，2019-2031

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章競爭格局

  • 公司簡介
    • Indivior PLC
    • Pfizer, Inc.
    • Johnson &Johnson Inc.
    • Mallinckrodt Pharmaceuticals
    • Teva Pharmaceuticals, Inc.
    • Par Pharmaceutical, Inc.
    • USWM, LLC
    • Valeant Pharmaceuticals
    • Greenyard Pharmaceutical Ltd
    • Cipla Health Limited
    • Perrigo
    • Haleon Group of Companies
    • Ventus Medical
    • Glenmark
    • Other Prominent Players

第11章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6671

Global substance abuse treatment market was valued US$ 11.8 Bn in 2023 and is expected to reach US$ 22.8 Bn by 2031 exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 11.8 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 8.60% 2030/2031 Value Projection: US$ 22.8 Bn
Figure 1. Global Substance Abuse Treatment Market Share (%), By Region, 2023
Global Substance Abuse Treatment Market - IMG1

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics:

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.

Detailed Segmentation:

  • Global Substance Abuse Treatment Market, By Type
    • Alcohol
    • Opioids (e.g., heroin, prescription painkillers)
    • Tobacco/nicotine
    • Cocaine
    • Marijuana
    • Methamphetamines
    • Other illicit drugs (Benzodiazepines, etc.)
  • Global Substance Abuse Treatment Market, By Treatment Type
    • Opioid
    • Methadone
    • Buprenorphine
    • Extended-release naltrexone
    • Lofexidine
    • Nicotine
    • Nicotine replacement therapies (available as a patch, inhaler, or gum)
    • Bupropion
    • Varenicline
    • Alcohol
    • Naltrexone
    • Disulfiram
    • Acamprosate
    • Tobacco
    • Clonidine
    • Nortriptyline
    • Others (Topiramate, Modafinil, etc.)
  • Global Substance Abuse Treatment Market, By Age Group
    • Adolescents
    • Adults
    • Geriatric
  • Global Substance Abuse Treatment Market, By Treatment Setting
    • Outpatient Treatment
    • Outpatient Clinics
    • Private Practices
    • Inpatient Treatment
    • Rehabilitation Centers
    • Hospitals
    • Residential Treatment Facilities
    • Detoxification Centers
  • Global Substance Abuse Treatment Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global Substance Abuse Treatment Market:
    • Indivior PLC
    • Pfizer, Inc.
    • Johnson & Johnson Inc.
    • Mallinckrodt Pharmaceuticals
    • Teva Pharmaceuticals, Inc.
    • Par Pharmaceutical, Inc.
    • USWM, LLC
    • Valeant Pharmaceuticals
    • Greenyard Pharmaceutical Ltd
    • Cipla Health Limited
    • Perrigo
    • Haleon Group of Companies
    • Ventus Medical
    • Glenmark
    • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Treatment Type
    • Market Snippet, By Age Group
    • Market Snippet, By Treatment Setting
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers:
  • Increasing consumption of drugs and alcohol
  • Growing support from government and NGOs
    • Restraints
  • Social stigma associated with substance dependence
  • Lack of adequate rehabilitation facilities
    • Opportunities
  • Untapped markets in developing countries
  • Company Market Share Analysis
  • Key Highlights
  • Market Trends
  • PEST Analysis
  • PORTER's Analysis
  • Recent Product Approvals/Launches
  • Mergers, Acquisitions, and Collaborations

4. Global Substance Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Substance Abuse Treatment Market, By Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Alcohol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Opioids (e.g., heroin, prescription painkillers)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Tobacco/nicotine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Cocaine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Marijuana
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Methamphetamines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other illicit drugs (Benzodiazepines, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Substance Abuse Treatment Market, By Treatment Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Opioid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Methadone
  • Buprenorphine
  • Extended-release naltrexone
  • Lofexidine
  • Nicotine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Nicotine replacement therapies (available as a patch, inhaler, or gum)
  • Bupropion
  • Varenicline
  • Alcohol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Naltrexone
  • Disulfiram
  • Acamprosate
  • Tobacco
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Clonidine
  • Nortriptyline
  • Others (Topiramate, Modafinil, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Substance Abuse Treatment Market, By Age Group, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Adolescents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Substance Abuse Treatment Market, By Treatment Setting, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Outpatient Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Outpatient Clinics
  • Private Practices
  • Inpatient Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Rehabilitation Centers
  • Hospitals
  • Residential Treatment Facilities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Detoxification Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Substance Abuse Treatment Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 - 2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profile
    • Indivior PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Pfizer, Inc.
    • Johnson & Johnson Inc.
    • Mallinckrodt Pharmaceuticals
    • Teva Pharmaceuticals, Inc.
    • Par Pharmaceutical, Inc.
    • USWM, LLC
    • Valeant Pharmaceuticals
    • Greenyard Pharmaceutical Ltd
    • Cipla Health Limited
    • Perrigo
    • Haleon Group of Companies
    • Ventus Medical
    • Glenmark
    • Other Prominent Players
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us